Docket
MS5031,
California State, Contra Costa County, Superior Court
(May 23, 2019)
Honorable Edward G. Weil, Charles S Treat, Treat Re Paraquat JCCP, presiding
Division | Martinez-Wakefield Taylor house |
Case Type | OTHER CIVIL PETITION |
Tags | Other, Civil Petition |
plaintiff/petitioner | PARAQUAT CASES |
plaintiff/petitioner | james krause |
plaintiff/petitioner | Keith Anderson |
Cite Docket
PARAQUAT CASES, MS5031 (California State, Contra Costa County, Superior Court)
+ More Snippets
Docket
2:18-cv-01587,
Ohio Southern District Court
(Dec. 6, 2018)
Judge Algenon L. Marbley, presiding, Magistrate Judge Kimberly A. Jolson
Torts to Land
Division | Columbus |
Flags | ADR-Atty, AttySealedAcc, JURY, PROTO |
Demand | $9,999,000 |
Cause | 28:1332 Diversity-Torts to Land |
Case Type | 240 Torts to Land |
Tags | 240 Tort to Land, Tort, Civil, 240 Tort to Land, Tort, Civil |
Deadline | Release of Transcript Restriction set for 4/29/2025. |
Interested Party | EQT Energy, LLC |
Plaintiff | J&R Passmore, LLC |
Plaintiff | Bruce Schuster |
Cite Docket
J&R Passmore, LLC et al v. Rice Drilling D, LLC et al, 2:18-cv-01587 (S.D.Ohio)
+ More Snippets
Docket
1:18-cv-00864,
Illinois Northern District Court
(Feb. 1, 2018)
Honorable Rebecca R. Pallmeyer, presiding
Statutory Actions - Other
06/03/2021 | ... seeking to assert the right of public access and unseal certain documents that have been filed with the Court 1289 is granted. None of the parties who filed a brief as permitted by ... |
09/25/2018 | ... themselves, pick one of these dates/times, and communicate their choice to the Court's courtroom deputy, Brenda_Rinozzi@ilnd.uscourts.gov, by 10:00 a.m. on 9/26/18. If none of the Court's suggestions work for counsel, then th... |
Cite Docket
In Re: Dealer Management Systems Antitrust Litigation, 1:18-cv-00864 (N.D.Ill.)
+ More Snippets
Document
Loop LLC v. CDK Global, LLC, 3:24-cv-00571, No. 241 (W.D.Wis Jan. 10, 2025)
Motion in Limine
At the summary judgment stage, CDK made a similar argument that none of the plaintiffs, including vendors like Loop, could establish an antitrust injury because their unauthorized access to the dealer management system violated laws ...
Cite Document
Loop LLC v. CDK Global, LLC, 3:24-cv-00571, No. 241 (W.D.Wis Jan. 10, 2025)
+ More Snippets
Document
King County et al v. Teva Pharmaceutical Industries Ltd et al, 2:21-cv-00477, No. 88 (W.D.Wash. Jan. 3, 2025)
KING COUNTY and CITY OF TACOMA, individually and on behalf of others similarly situated,
1 2 3 4 5 6 7 8 9 WHEREAS, the Parties, through their respective counsel of record, hereby agree to the terms of this stipulation and order for additional protection of confidential documents produced by non-parties; THEREFORE, in view of the foregoing, and because the Parties hereto, by and through their respective counsel, have agreed to the following Stipulation and Order Regarding Non-Party Confidentiality Designations, pursuant to Federal Rule of Civil Procedure 26(c) and having determined that good cause exists for the entry of this Order, the Parties stipulate and request the Court order as follows:
To the extent any subpoenaed non-party deems it appropriate to designate documents produced in this matter as “HIGHLY CONFIDENTIAL – ATTORNEYS’ EYES ONLY” under the Stipulated Protective Order (Dkt. No. 24), and to the extent the non-party in good faith believes that the documents it is producing contain material relating to highly sensitive business matters, the disclosure of which could cause direct and substantial harm to the non-party, it may designate such non-party may further designate such documents as
For avoidance of doubt, materials designated as “HIGHLY CONFIDENTIAL – OUTSIDE ATTORNEYS’ EYES ONLY” may still be disclosed to the parties’ Outside Counsel of Record as defined at ¶ 4.2.a.
This stipulation and order is binding upon, without limitation, all current and future parties in this action (including their respective corporate parents, subsidiaries, affiliates, successors, and attorneys and all other representatives or agents), and their counsel; all other persons or entities authorized under the Stipulated Protective Order or any other order of this Court to receive or view Highly Confidential Material; and all other interested persons or entities with actual or constructive notice of this stipulation and or the Stipulated Protective Order.
Cite Document
King County et al v. Teva Pharmaceutical Industries Ltd et al, 2:21-cv-00477, No. 88 (W.D.Wash. Jan. 3, 2025)
+ More Snippets
Document
Pacira Pharmaceuticals, Inc. v. Research Development Foundation, 2:21-cv-02241, No. 383 (D.Nev. Dec. 12, 2024)
Thus, a “particularized showing” under the good-cause standard of Federal Rule of Civil Procedure 26(c) will “suffice[ ] to warrant preserving the secrecy of sealed discovery material attached to non-dispositive motions.” Foltz, 331 F.3d at 1135.
Thus, the compelling reasons standard is invoked even if the dispositive motion, or its attachments, were previously filed under seal or protective order.
Compelling reasons may justify sealing court records “when such ‘court files might have become a vehicle for improper purposes’” such as releasing trade secrets.
The Supreme Court has instructed that a sealing order should be “limited to information that was actually sensitive,” that is only the parts of the material necessary to protect the compelling interest.
The parties were ordered to file redacted versions of their opening and responsive post-trial briefs and findings of fact and conclusions of law by January 3, 2025.
Cite Document
Pacira Pharmaceuticals, Inc. v. Research Development Foundation, 2:21-cv-02241, No. 383 (D.Nev. Dec. 12, 2024)
+ More Snippets
Document
Pacira Pharmaceuticals, Inc. v. Research Development Foundation, 2:21-cv-02241, No. 372 (D.Nev. Nov. 20, 2024)
Cite Document
Pacira Pharmaceuticals, Inc. v. Research Development Foundation, 2:21-cv-02241, No. 372 (D.Nev. Nov. 20, 2024)
+ More Snippets
Document
Pacira Pharmaceuticals, Inc. v. Research Development Foundation, 2:21-cv-02241, No. 368 (D.Nev. Nov. 7, 2024)
Cite Document
Pacira Pharmaceuticals, Inc. v. Research Development Foundation, 2:21-cv-02241, No. 368 (D.Nev. Nov. 7, 2024)
+ More Snippets
Document
Pacira Pharmaceuticals, Inc. v. Research Development Foundation, 2:21-cv-02241, No. 366 (D.Nev. Nov. 6, 2024)
Cite Document
Pacira Pharmaceuticals, Inc. v. Research Development Foundation, 2:21-cv-02241, No. 366 (D.Nev. Nov. 6, 2024)
+ More Snippets
Document
Pacira Pharmaceuticals, Inc. v. Research Development Foundation, 2:21-cv-02241, No. 360 (D.Nev. Oct. 15, 2024)
Cite Document
Pacira Pharmaceuticals, Inc. v. Research Development Foundation, 2:21-cv-02241, No. 360 (D.Nev. Oct. 15, 2024)
+ More Snippets
Document
PARAQUAT CASES, MS5031, Stipulation Order No Fee 1-Stipulation__Order_No_FeeRE_SUPPLEMENTAL_BRIEFING_SCHEDULE_RE_DEFTS_MTN_TO_EXCLUDE_DR_WELLS (Cal. St., C...
Cite Document
PARAQUAT CASES, MS5031, Stipulation Order No Fee 1-Stipulation__Order_No_FeeRE_SUPPLEMENTAL_BRIEFING_SCHEDULE_RE_DEFTS_MTN_TO_EXCLUDE_DR_WELLS (Cal. St., Contra Costa Co., Super. Ct. Oct. 10, 2024)
+ More Snippets
Document
In Re: Celsius Network LLC, 1:23-cv-10036, No. 62 (S.D.N.Y. Oct. 1, 2024)
Cite Document
In Re: Celsius Network LLC, 1:23-cv-10036, No. 62 (S.D.N.Y. Oct. 1, 2024)
+ More Snippets
Document
Pacira Pharmaceuticals, Inc. v. Research Development Foundation, 2:21-cv-02241, No. 331 (D.Nev. Sep. 23, 2024)
Cite Document
Pacira Pharmaceuticals, Inc. v. Research Development Foundation, 2:21-cv-02241, No. 331 (D.Nev. Sep. 23, 2024)
+ More Snippets
Document
Pacira Pharmaceuticals, Inc. v. Research Development Foundation, 2:21-cv-02241, No. 316 (D.Nev. Sep. 20, 2024)
Cite Document
Pacira Pharmaceuticals, Inc. v. Research Development Foundation, 2:21-cv-02241, No. 316 (D.Nev. Sep. 20, 2024)
+ More Snippets
Document
Pacira Pharmaceuticals, Inc. v. Research Development Foundation, 2:21-cv-02241, No. 312 (D.Nev. Sep. 19, 2024)
Cite Document
Pacira Pharmaceuticals, Inc. v. Research Development Foundation, 2:21-cv-02241, No. 312 (D.Nev. Sep. 19, 2024)
+ More Snippets